Skip to main content
. 2018 Aug 21;8(4):239–254. doi: 10.1159/000490806

Fig. 3.

Fig. 3

Immunohistochemistry for K19 and clinical outcomes of 125 HCCs. a Examples of immunohistochemistry staining of K19 in HCCs classified into 5 groups according to the percentage of tumor cells with positive staining. b Kaplan-Meier survival curves for disease-free survival (DFS), overall survival (OS), and extrahepatic metastasis (EHM) recurrence-free survival (EFS) according to K19 expression status.